RBPJ and Adams-Oliver syndrome: While these findings do not preclude the possibility that other cell types contribute to these defects, the fact that having the N1+/null Rbpj+/E89G genotype in the endothelium is both necessary and sufficient to cause AOS-like phenotypes strongly suggests that defective N1-signaling in the vascular endothelium is a major driver of pathogenesis.